Podcast, Other
E63: Insurrection indictments, human rights in the US and abroad, groundbreaking MS study and more
- Chamath Palihapitiya forecasts a landslide "red wave" in the November midterm elections, predicting Democrats will suffer severe losses if the January 6 narrative dominates over inflation and economic concerns for the upcoming 10 months.
- Palihapitiya anticipates bipartisan support to reform the Electoral Count Act, estimating potential for 60 votes, and expects similar cross-aisle cooperation on legislation to curb congressional insider trading, which could improve political momentum into 2024.
- David Sacks predicts a decade of negative geopolitical narratives regarding China, asserting that US political and economic interests will continue to frame China as a primary adversary within a multi-hundred-year economic cycle.
- Jason Friedberg and J. Cal observe a weakening of the Western consensus on human rights compared to the 1980s Cold War era, suggesting the West faces strategic difficulties in engaging, admonishing, or disengaging from human rights violators.
- J. Cal warns that political figures across the spectrum are exploiting events surrounding January 6 to expand surveillance and prosecutorial powers against American citizens, while noting a high likelihood of severe legal consequences for Oath Keepers.
- Nick S. projects a "weird longitudinal pattern" in education where women continue to pursue degrees while a significant portion of men enter the workforce early, potentially leading to a generation of miseducated men and reduced student enrollment due to savings from stimulus checks.
- David S. and J. Cal anticipate clinical trials starting immediately to test T-cell therapies against the Epstein-Barr virus, aiming to determine if eliminating the virus can halt future Multiple Sclerosis (MS) cases and stop the need for ongoing MS treatments.
- Both David S. and J. Cal identify potential for prophylactic EBV treatments costing as little as 5 cents per pill, noting that data analysis from US military blood samples could catalyze significant investment in these therapeutic strategies.
- J. Cal expects that replacing accredited investor laws with a test-based and capped investment model (allowing 5-10% of recent tax return income) could fundamentally alter upward mobility in the US, characterizing stricter SEC regulations as an overreaction.
- J. Cal suggests that the ability to grow biological matter and organs in bioreactors via gene editing may soon eliminate the need for animal sources, describing the potential as tremendous.
- J. Cal argues that domestic issues, such as human rights in Hong Kong, may be deprioritized in favor of addressing internal US problems, as the public grows exhausted by external geopolitical arguments.